Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role Of Hysterectomy In The Treatment Of Borderline Ovarian Tumors

NCT06825468 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT06825468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06825468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role Of Hysterectomy In The Treatment Of Borderline Ovarian Tumors
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Completed
Start date
January 10, 2022
Completion date
January 31, 2025
Enrollment
168 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hysterectomy